Research use only · EU-warehoused · COA on every batch · HPLC ≥99% · Shipment 2–5 days
Log in Register
Research Journal

The science, examined.

Plain-spoken notes on the compounds we supply — what the literature shows, how to read a COA, and the protocols that protect your data. Cited, never hyped.

All Bioregulators Comparisons Guides Gut Hormonal Immune In the news Metabolic & longevity Methods & QC Nootropics Regulation Sexual health Skin & matrix Sleep Tissue repair
The Solvent Problem: Peptide Manufacturing Is Scaling Into a Regulatory Squeeze Methods & QC
Latest

The Solvent Problem: Peptide Manufacturing Is Scaling Into a Regulatory Squeeze

GLP-1 demand pushed peptide synthesis to metric-ton scale. At the same moment the EU restricted DMF and added DMAc and NEP to Annex XVII. The chemistry that makes peptides runs…

Aug 2026 · 5 min read
Why a Generic Peptide Is Harder Than a Generic Pill: Inside FDA’s July 2026 Guidance Revision Regulation

Why a Generic Peptide Is Harder Than a Generic Pill: Inside FDA’s July 2026 Guidance Revision

FDA revised 17 product-specific guidances for generic peptides and withdrew its 2021 synthetic peptide guidance. The five areas it targeted explain why the same…

Aug 2026 · 7 min read
Designed Peptides in August 2026: Three Papers, Three Different Meanings of “Designed” Methods & QC

Designed Peptides in August 2026: Three Papers, Three Different Meanings of “Designed”

In one month: computationally designed antimicrobial nanopores that work in mice, an engineered peptide nanopore that detects single α-synuclein species, and LLM-assisted design of…

Aug 2026 · 6 min read
Mimrylo (Rusfertide): The FDA Just Approved a Peptide That Mimics a Hormone Most People Have Never Heard Of In the news

Mimrylo (Rusfertide): The FDA Just Approved a Peptide That Mimics a Hormone Most People Have Never Heard Of

On 28 August 2026 FDA approved Mimrylo (rusfertide) for polycythemia vera — the first hepcidin-mimetic peptide medicine. The mechanism is iron restriction, and it…

Aug 2026 · 5 min read
Avexitide: The Peptide That Blocks the Receptor Ozempic Activates In the news

Avexitide: The Peptide That Blocks the Receptor Ozempic Activates

Avexitide is a GLP-1 receptor antagonist — the same target as semaglutide, the opposite direction. In August 2026 it cut severe hypoglycaemic events by…

Aug 2026 · 5 min read
The Hormone That Kept Turning Into Amyloid: Why Amylin Took Thirty Years to Become a Drug Methods & QC

The Hormone That Kept Turning Into Amyloid: Why Amylin Took Thirty Years to Become a Drug

Human amylin forms amyloid fibrils in the pancreas, which is why it was undruggable. Three proline substitutions borrowed from rat amylin fixed it. And…

Aug 2026 · 6 min read
The Same Peptide, Injected and Swallowed: What Zenagamtide’s Two Trials Cost to Compare Methods & QC

The Same Peptide, Injected and Swallowed: What Zenagamtide’s Two Trials Cost to Compare

Novo Nordisk ran one peptide two ways in the same trial network. The top oral arm received about nine times more drug per week…

Aug 2026 · 4 min read
Peptides Go Mainstream: What Hims & Hers’ 2026 Move Tells Us About the Category In the news

Peptides Go Mainstream: What Hims & Hers’ 2026 Move Tells Us About the Category

A listed telehealth company with 2.9 million subscribers is preparing to sell peptides, and is already running stability testing on BPC-157. What that says…

Aug 2026 · 7 min read
A “Research Use Only” Label Is Not a Legal Status: What FDA and Lilly Established in 2026 Regulation

A “Research Use Only” Label Is Not a Legal Status: What FDA and Lilly Established in 2026

FDA set aside an RUO disclaimer and ruled on the rest of the website instead. Lilly then asked payment processors and carriers to cut…

Aug 2026 · 6 min read
Methods & QC

GHK-Cu + KPV Blend: Naming, Formulations and What the COA Should Show

Search for the two-peptide blend of GHK-Cu and KPV and you will not find one product. You will find at least eight different names…

Aug 2026 · 11 min read
Ecnoglutide: A cAMP-Biased GLP-1 Agonist Approved in China, Not Yet in Europe or the US Metabolic & longevity

Ecnoglutide: A cAMP-Biased GLP-1 Agonist Approved in China, Not Yet in Europe or the US

Most GLP-1 receptor agonists activate the receptor’s two main signalling arms — cAMP production and β-arrestin recruitment — more or less together. Ecnoglutide (XW003)…

Aug 2026 · 8 min read
What Is ALY688? The Peptide Built to Get Around Adiponectin’s Manufacturing Problem Metabolic & longevity

What Is ALY688? The Peptide Built to Get Around Adiponectin’s Manufacturing Problem

Adiponectin is one of the more interesting hormones in metabolic research: a fat-derived signal whose levels fall exactly when the body needs more of…

Aug 2026 · 10 min read
Previous Page 1 of 17 Next

New research, in your inbox

Occasional, considered notes on the compounds and the literature. No noise.

Subscribe & earn 500 points